Clinical Trial Update: Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update summarizing long-term safety, efficacy, and durability of EN3835 in the treatment and retreatment of plantar fibromatosis; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plantar Fibromatosis

Drugs mentioned

• EN3835

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Plantar Fibromatosis | Phase 3 | Status: COMPLETED